Richard A. Krause

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

Two-phase increase in the maximum size of life over 3.5 billion years reflects biological innovation and environmental opportunity

Jonathan L. Payne, Alison G. Boyer, James H. Brown et al. · Proceedings of the National Academy of Sciences · 2008 · 310 citations · Full text

A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

J. Novick, Philip B. Miner, Richard A. Krause et al. · Alimentary Pharmacology & Therapeutics · 2002 · 290 citations · Full text

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Gautam Goel, Tim King, A. James M. Daveson et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 142 citations · Full text

Autoimmune Disease, Allergy, Epitope-specific Immunotherapy +10